Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 629-764-9 | CAS number: 164524-02-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
- Toxic effect type:
- dose-dependent
Effects on fertility
Description of key information
The HYDROTOPES Category comprises the following 6 substances:
STS - Sodium toluene 4-sulphonate (CAS 657-84-1, EC 211-522-5)
SXS - Sodium (xylenes and 4-ethylbenzene) sulfonates (EC 701-037-1)
NH4XS - Ammonium (xylenes and 4-ethylbenzene) sulfonates (EC 943-024-5)
SCS - Sodium p-cumenesulphonate (CAS 15763-76-5, EC 239-854-6)
KCS - Potassium p-cumenesulphonate (CAS 164524-02-1, EC 629-764-9)
NH4CS - Ammonium p-cumenesulphonate (CAS 680972-33-2, EC 811-484-5)
In addition CaXS (Calcium Xylenesulphonate, CAS 28088-63-3, EC 248-829-9) was evaluated for complete the assessment despite it is not registered under REACH.
In a reproductive and developmental toxicity screening study (OECD 421) Sodium p-toluene sulphonate was administered to male and female Sprague-Dawley rats by oral gavage at dose levels of 0, 100, 300 or 1000 mg/kg bw/day on a total of 46 days before the start of mating, during the mating period and after the end of mating to male rats and before the start of mating, during the mating and gestation periods up to day 3 of lactation to female rats. Males and females in the 1000 mg/kg bw/day group showed diarrhoea or soft faeces, and males showed mild inflammatory cell infiltration of the lamina propria and squamous cell hyperplasia in the limiting ridge of the stomach. There were no effects from administration of the substance on the reproductive function or development and growth of the next generation in any dose group. Therefore, it was considered that the NOAEL for parental toxicity was 300 mg/kg bw/day and the NOAEL for reproductive and developmental toxicity was 1000 mg/kg bw/day.
The 90-day oral rat and oral mouse studies and the 2-year chronic dermal rat and mouse studies (OECD 453) on Sodium (xylenes and 4-ethylbenzene) sulfonates included examination of sex organs of both sexes. No treatment related effects on reproductive organs were reported at doses.
No treatment related effects on reproductive organs were reported in any study. A new OECD 443 was performed on Sodium (xylenes and 4-ethylbenzene) sulfonates which is the most representative member of the hydrotropes category since it contains a significant proportion of both mono-alkyl (ethyl) and di-alkyl (dimethyl) chemical species and thus best represents the substances within the category.
The available results on reproductive and developmental toxicity are:
STS, OECD 421 (2004): NOAEL = 1000 mg a.i./kg bw
SXS, OECD 443 (2022): NOAEL for SYSTEMIC TOXICITY = 1000 mg/kg/day for P and F1 male/female
NOAEL for REPRODUCTION and DEVELOPMENT = 1000 mg/kg/day
The NOAEL value used for the risk assessment for toxicity to reproduction is 1000 mg/kg bw from the new OECD 443 performed on SXS.
Effect on fertility: via oral route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 1 000 mg/kg bw/day
- Study duration:
- subacute
- Species:
- rat
- Quality of whole database:
- Sufficient to meet requirements.
Effect on fertility: via inhalation route
- Endpoint conclusion:
- no study available
Effect on fertility: via dermal route
- Endpoint conclusion:
- no study available
Effects on developmental toxicity
Description of key information
The HYDROTOPES Category comprises the following 6 substances:
STS - Sodium toluene 4-sulphonate (CAS 657-84-1, EC 211-522-5)
SXS - Sodium (xylenes and 4-ethylbenzene) sulfonates (EC 701-037-1)
NH4XS - Ammonium (xylenes and 4-ethylbenzene) sulfonates (EC 943-024-5)
SCS - Sodium p-cumenesulphonate (CAS 15763-76-5, EC 239-854-6)
KCS - Potassium p-cumenesulphonate (CAS 164524-02-1, EC 629-764-9)
NH4CS - Ammonium p-cumenesulphonate (CAS 680972-33-2, EC 811-484-5)
In addition CaXS (Calcium Xylenesulphonate, CAS 28088-63-3, EC 248-829-9) was evaluated for complete the assessment despite it is not registered under REACH.
The study with Calcium Xylenesulphonate performed under similar condition of OECD 414 guideline showed no adverse effects. In this developmental toxicity study on Calcium Xylenesulphonate, thirty (30) female rats received 0, 150, 1500 or 3000 mg test substance/kg bw/day by oral gavage on days 6 to 15 of gestation. Clinical symptoms were noted daily through day 20. Body weight and food consumption were recorded every three days through day 20. All females were macroscopically examined on day 20. The uteri were removed, weighed and examined for number of corpora lutea, implant sites, and number, and location of foetuses and resorptions. Foetuses were inspected on total number, sex, weight and external, visceral (one-half) and skeletal (one-half) defects. One death occurred at the 1500 mg/kg bw/day dose but it was considered a gavage injury. There were no abnormal clinical observations or necropsy findings. There were no effects on body weight or body weight gain. There was a siginifcant increase in food consumption for the 3000 mg/kg bw/day dose during gestation interval (day) 12 -16, but this was considered normal biological variation and not a direct effect of the substance. All indices were comparable to the corresponding controls. The NOAEL based on active ingredient of the test substance is 936 mg/kg bw/day. The NOAEL for both maternal and foetal toxicity was the highest dose tested and the conclusion of the study was no indications of developmental toxicity including teratogenesis.
The OECD 414 performed on Sodium p-cumenesulphonate confirms the absence of effects on developmental toxicity.
OECD 414 was performed on a second species (rabbits) according OECD Guideline 414 to assess the influence of Sodium (xylenes and 4-ethylbenzene) sulfonates on on embryo-fetal survival and development when administered during the organogenesis and fetal growth phases of pregnancy in the New Zealand White Rabbit. Three groups of 22 females received Sodium Xylene Sulphonate at doses of 100, 300 or1000 mg/kg/day by oral gavage administration at a volume-dose of 5 mL/kg body weight from Day 6 to Day 28 after mating, inclusive. A similarly constituted Control group received the vehicle, purified water, at the same dose volume and for the same duration as those receiving the test item. Based on the results obtained in this study of embryo-fetal development, it was concluded that the dose level of 1000 mg/kg/day represented the No Observed Adverse Effect Level (NOAEL) for maternal toxicity and for embryo-fetal survival, growth and development.
A new OECD 443 was performed on Sodium (xylenes and 4-ethylbenzene) sulfonates which is the most representative member of the hydrotropes category since it contains a significant proportion of both mono-alkyl (ethyl) and di-alkyl (dimethyl) chemical species and thus represents both the mono-alkyl and di-alkyl substances contained within the category.
The available results on developmental toxicity are:
SCS, OECD 414 (2020): NOAEL = 1000 mg a.i./kg bw
SXS, OECD 414 (rabbits, 2017): NOAEL = 1000 mg a.i./kg bw
CaXS, similar to OECD 414 (1994): NOAEL = 936 mg a.i./kg bw
SXS, OECD 443 (2022):NOAEL = 1000 mg a.i./kg/bw
The NOAEL value used for the risk assessment for developmental toxicity is 936 mg/kg bw from the OECD 414 performed on CaXS.
Effect on developmental toxicity: via oral route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 936 mg/kg bw/day
- Study duration:
- subacute
- Species:
- rat
- Quality of whole database:
- The available developmental study was fully documented and conducted in accordance with GLP. A study in a second species (New Zealand white rabbit) confirms this result with a NOEL of 1000 mg/kg bw/day
Effect on developmental toxicity: via inhalation route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via dermal route
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
From the available studies of hydrotropes, there is no concerns for reprodution and developmenatl toxicity.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.